Skip to content

Author

Ying-Chuan Wang

We have 1 of 21 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Attenuation of serum inflammatory cytokines in hospitalized COVID-19 patients treated with NRICM101: A preliminary observational study.

NRICM101 administration was associated with reduced serum levels of key proinflammatory cytokines, indicating a potential anti-inflammatory effect, and may serve as an adjunctive therapy for patients with COVID-19-related hyperinflammation.

Ying-Chuan Wang, Ya-Hsin Yao, Sunny Jui-Shan Lin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.